Suven Pharmaceuticals Limited (SUVENPHAR) — Strategic Asset Allocation Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Strategic Asset Allocation Index of 46.2% as of September 2022. Strategic assets (PP&E of Rs6.95 Billion plus long-term investments of Rs-) total Rs6.95 Billion, measured against net assets of Rs15.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Suven Pharmaceuticals Limited Strategic Asset Allocation Index (2019–2022)
This chart shows how Suven Pharmaceuticals Limited's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2022, the index stands at 46.2%, representing strategic assets of Rs6.95 Billion against net assets of Rs15.03 Billion INR. Explore Suven Pharmaceuticals Limited cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Suven Pharmaceuticals Limited (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Suven Pharmaceuticals Limited from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see SUVENPHAR market cap overview.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 36.8% | Rs5.62 Billion | Rs5.62 Billion | Rs- | Rs15.27 Billion | ▼ -8.5 pp |
| 2021 | 45.3% | Rs5.35 Billion | Rs5.35 Billion | Rs- | Rs11.81 Billion | ▼ -8.6 pp |
| 2020 | 53.9% | Rs4.56 Billion | Rs4.56 Billion | Rs- | Rs8.45 Billion | ▼ -10.3 pp |
| 2019 | 64.3% | Rs3.79 Billion | Rs3.79 Billion | Rs- | Rs5.90 Billion | — |